On December 2, 2019 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that the company plans to present at the following conferences in December (Press release, Iovance Biotherapeutics, DEC 2, 2019, View Source [SID1234551829]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Jaffray 31st Annual Healthcare Conference in New York, Dec. 3-5, 2019
Location: Lotte New York Palace
Date/Time: Tuesday, Dec. 3, at 11:30 a.m. EST

Evercore ISI 2nd Annual HealthCONx Conferencein Boston, Dec. 3-5, 2019
Location: Four Seasons Hotel Boston
Date/Time: Wednesday, Dec. 4, at 1:35 p.m. EST
Live and archived webcasts of the presentations will be available in the Investors section of the Iovance website at View Source